04 Feb 2021

FY20 trading update shows surge in sales

Novacyt SAS (NCYT:LON) | 54.8 0.9 2.9% | Mkt Cap: 38.7m

- Vadim Alexandre | Liam Gascoigne-Cohen
- 10 pages

Novacyt recently announced a positive trading update for the year ended 31 December 2020 (FY20E). The update outlined the significant demand for the Group’s COVID-19 test offering over the period. Sales have resulted in a surge in revenues for FY20E which is 24- fold higher than FY19A revenues (€13.1m) and exceeded our estimates by €23.8m (SP Angel FY20E: €287.8m).

Sign up to access

Get access to our full offering from over 30 providers

FY20 trading update shows surge in sales

Novacyt SAS (NCYT:LON) | 54.8 0.9 2.9% | Mkt Cap: 38.7m

Published: 04 Feb 2021
Author: Vadim Alexandre | Liam Gascoigne-Cohen
Pages: 10

Novacyt recently announced a positive trading update for the year ended 31 December 2020 (FY20E). The update outlined the significant demand for the Group’s COVID-19 test offering over the period. Sales have resulted in a surge in revenues for FY20E which is 24- fold higher than FY19A revenues (€13.1m) and exceeded our estimates by €23.8m (SP Angel FY20E: €287.8m).